Langharan, Perlita M.
HRN: 27-82-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFTRIAXONE 1G (VIAL)
09/19/2025
09/26/2025
IV
2g
OD
Capmr
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines